Immune Evaluation with Skin Tests in Prostatic Carcinoma

Abstract
By intradermal injection of 3 recall antigens, nonspecific secondary cell immunity was studied in 61 patients with prostatic carcinomas. Immune competence is lower in patients with metastatic disease. Skin tests have a short-term prognostical value.

This publication has 1 reference indexed in Scilit: